Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial
{{output}}
Metabotropic glutamate receptor 5 (mGluR5) is involved in cocaine reward processing and addiction. Preclinical studies suggest that blocking this receptor inhibits cocaine self-administration and seeking behavior in rodents. We assessed a selective noncompetit... ...
